Evelina Maines

Dr. Evelina Maines

Azienda Proviciale per i Servizi Sanitari di Trento, Italy, Trento, Trentino-Alto Adige, Italy
orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 June 2021 in Biomolecules
Verified
Journal Article
Open access
PDF file
VGVincenza Gragnaniello
Vincenza Gragnaniello
Alessandro P. BurlinaAlessandro P. Burlina
Alessandro P. Burlina
Giulia PoloGiulia Polo
Giulia Polo
AGAntonella Giuliani
Antonella Giuliani
LSLeonardo Salviati
Leonardo Salviati
alberto burlinaalberto burlina
alberto burlina
Fabry disease (FD) is a progressive multisystemic lysosomal storage disease. Early diagnosis by newborn screening (NBS) may allow for timely treatment, thus preventing future irreversible organ damage. We present the results of 5.5 years of NBS for FD by α-galactosidase A activity and globotriaosylsphingosine (lyso-Gb3) assays in dried blood spot through a multiplexed MS/MS assay. Furthermore, we report our experience with long-term follow-up of positive subjects. We screened more than 170,000 newborns and 22 males were confirmed to have a GLA gene variant, with an incidence of 1:7879 newborns. All patients were diagnosed with a variant previously associated with the later-onset phenotype of FD or carried an unclassified variant (four patients) or the likely benign p.Ala143Thr variant. All were asymptomatic at the last visit. Although lyso-Gb3 is not considered a reliable second tier test for newborn screening, it can simplify the screening algorithm when its levels are elevated at birth. After birth, plasma lyso-Gb3 is a useful marker for non-invasive monitoring of all positive patients. Our study is the largest reported to date in Europe, and presents data from long-term NBS for FD that reveals the current incidence of FD in northeastern Italy. Our follow-up data describe the early disease course and the trend of plasma lyso-Gb3 during early childhood.

8 November 2011 in Journal of Bone and Mineral Metabolism
Verified
Journal Article
Closed access
PDF file
EMEvelina Maines
Evelina Maines
EMElena Monti
Elena Monti
FDFrancesco Doro
Francesco Doro
GMGrazia Morandi
Grazia Morandi
PCPaolo Cavarzere
Paolo Cavarzere
FAFranco Antoniazzi
Franco Antoniazzi

15 March 2014 in Journal of Bone and Mineral Metabolism
Verified
Journal Article
Closed access
PDF file
GMGrazia Morandi
Grazia Morandi
EMEvelina Maines
Evelina Maines
Claudia PionaClaudia Piona
Claudia Piona
EME. Monti
E. Monti
Marco SandriMarco Sandri
Marco Sandri
FAFranco Antoniazzi
Franco Antoniazzi

18 July 2020 in Journal of Inherited Metabolic Disease
Verified
Journal Article
Closed access
PDF file
EMEvelina Maines
Evelina Maines
GCGiulio Catesini
Giulio Catesini
SBSara Boenzi
Sara Boenzi
AMAntonella Mosca
Antonella Mosca
MCManila Candusso
Manila Candusso
CDCarlo Dionisi-Vici
Carlo Dionisi-Vici

15 March 2023 in Journal of Inherited Metabolic Disease
Verified
Journal Article
Closed access
DMDiego Martinelli
Diego Martinelli
GCGiulio Catesini
Giulio Catesini
BGBenedetta Greco
Benedetta Greco
AGAlessia Guarnera
Alessia Guarnera
CPChiara Parrillo
Chiara Parrillo
CDCarlo Dionisi-Vici
Carlo Dionisi-Vici

29 December 2017 in Pediatric Blood & Cancer
Verified
Journal Article
Closed access
PDF file
ETElisa Tadiotto
Elisa Tadiotto
EMEvelina Maines
Evelina Maines
DDDaniela Degani
Daniela Degani
RBRita Balter
Rita Balter
ABAndrea Bordugo
Andrea Bordugo
Simone CesaroSimone Cesaro
Simone Cesaro